Distribution deal to stoke sales at pain-pump maker Symbios
The Indianapolis company expects the pact will boost revenue from $1 million now to more than $10 million in 2013.
Medical Devices
Articles
Medical device maker expanding in Fort Wayne
L.H. Medical Corp. said it plans to create up to 65 jobs by 2013 and invest $5.4 million to more than triple the size of its manufacturing operations.
Zimmer quarterly profit jumps on lower costs
Warsaw-based Orthopedic implant maker Zimmer Holdings Inc. reported net income of $191.1 million, or 96 cents per share. Sales fell 1 percent to $965 million from $975.6 million.
Cook stent could prevent more amputations, study finds
A drug-coated stent from Indiana-based Cook Medical was more effective than standard therapy for patients with blockages in an upper-leg artery, a study found.
IU surgeon gets $2 million for heart pump
IU School of Medicine associate professor Mark Rodefeld will use funding to further develop the pump, intended to combat a congenital heart defect that kills many children in their first year of life.
VoCare raises $2.2 million for telehealth device
The local startup expects to raise another $1.3 million this year and launch pilots of a new mobile device connecting patients with doctors.
Pearl IRB first firm in state to pre-screen clinical drug trials
Two former Eli Lilly and Co. employees launched the firm that promises to attract more clinical trial business to the state.
Biomet investing $26M to expand, create nearly 280 jobs
Orthopedics giant Biomet Inc. plans to invest $26 million to grow operations in its hometown of Warsaw, adding 278 jobs by
the end of 2012.
Bedsore preventer turns to detection
Changes in reimbursement could fuel market for WoundVision’s product.
Indiana universities offer cash incentives for technology transfer
The Indiana Clinical and Translational Sciences Institute awarded $750,000 to 10 teams of researchers.
Senator asks Zimmer for info about product complaints
Inquiry stemmed from an article in the New York Times about a dispute between the Warsaw-based maker of artificial hip and knee joints and two of its consultants.
Medical device maker plans Warsaw expansion
Biomet could add about 280 jobs with the $26 million project, which would lead to some manufacturing being transferred from
New Jersey.
Medical device firm eyeing Indianapolis growth
Greatbatch Medical wants to expand its facility on the east side of Indianapolis to accommodate its entrance into the orthopedics
market. The
New York-based company specializes in cardiovascular products.
Positron has billion-dollar hopes for medical-imaging scanner
A maker of medical imaging equipment that recently moved its headquarters to Fishers has grand plans to reach $1 billion in
sales and build a multimillion-dollar cyclotron facility in five years. But history shows Positron Corp. has been far better
at losing money than making it.
Indiana’s growth in life sciences jobs beats national average
Bloomington led the nation as the No. 1 small city in medical devices and equipment.
Judge rejects Guidant’s defibrillator plea deal
A federal judge has rejected Guidant Corp.'s guilty plea to charges it hid defects in heart defibrillators, after some
doctors and patients complained about the $296 million deal.
Medical device startup FlowCo enlists Guidant alums
The upstart developer of a device to help doctors choose the right-sized stent to prop open clog-prone arteries has brought
aboard former Guidant Corp. executives, including Bill McConnell. Their regulatory and marketing expertise could help FlowCo Inc. bring its artery-measurement
product to market as soon as 2011.
Hill-Rom to cut 160 more jobs
The Batesville-based medical equipment supplier said it expects the cuts to save the company about $16 million a year.
Bill kicks off years of change for local health care players
Sweeping changes phase in slowly for most, but insurers, hospitals, drug companies, employers, workers, medical device makers
and more will eventually feel impact.
Reform offers risk, opportunities for Lilly, WellPoint
Drugmakers and insurers could gain millions of customers under the legislation, but the industry also will pay new fees and
face stricter rules that may shrink profit and fuel mergers.